Compounds > n-nitrosobis(2-acetoxypropyl)amine
Page last updated: 2024-12-07

n-nitrosobis(2-acetoxypropyl)amine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID91675
MeSH IDM0060711

Synonyms (7)

Synonym
ccris 2014
bis(2-acetoxypropyl)nitrosamine
2-propanol, 1,1'-(n-nitrosoimino)di-, diacetate
n-nitrosobis(2-acetoxypropyl)amine
60414-81-5
(nitrosoazanediyl)di(propane-1,2-diyl) diacetate
DTXSID20975822
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
n-nitroso-2,6-dimethylmorpholine
N-nitroso-2,6-dimethylmorpholine: RN given refers to parent cpd without isomeric designation		1.9610
diisopropanolnitrosamine
diisopropanolnitrosamine: experimental carcinogen. N,N-bis(2-hydroxypropyl)nitrosamine : A nitrosamine that is dipropylamine in which the hydrogen attached to the nitrogen has been replaced by a nitroso group. It is a genotoxic carcinogen, targeting the lung, liver, thyroid, and kidney.		2.6530diol;
nitrosamine;
secondary alcohol		carcinogenic agent
n-nitroso(2-hydroxypropyl)(2-oxopropyl)amine
N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine: structure		1.9610
n-nitrosobis(2-oxobutyl)amine
N-nitrosobis(2-oxobutyl)amine: structure given in first source		1.9610
azaserine
Azaserine: Antibiotic substance produced by various Streptomyces species. It is an inhibitor of enzymatic activities that involve glutamine and is used as an antineoplastic and immunosuppressive agent.. azaserine : A carboxylic ester resulting from the formal condensation of the carboxy group of diazoacetic acid with the alcoholic hydroxy group of L-serine. An antibiotic produced by a Streptomyces species.		1.9710carboxylic ester;
diazo compound;
L-serine derivative;
non-proteinogenic L-alpha-amino acid		antifungal agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
glutamine antagonist;
immunosuppressive agent;
metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Carcinoma, Epidermoid
[description not available]		01.9610
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		01.9610
Adenoma, Prostatic
[description not available]		01.9610
Cancer of Prostate
[description not available]		01.9610
Cancer of the Urethra
[description not available]		01.9610
Carcinoma, Squamous Cell
A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)		01.9610
Prostatic Hyperplasia
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.		01.9610
Prostatic Neoplasms
Tumors or cancer of the PROSTATE.		01.9610
Urethral Neoplasms
Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.		01.9610
Cancer of Lung
[description not available]		02.3620
Experimental Neoplasms
[description not available]		02.6530
Lung Neoplasms
Tumors or cancer of the LUNG.		02.3620
Cancer of Liver
[description not available]		01.9510
Liver Neoplasms
Tumors or cancer of the LIVER.		01.9510
Cancer of Lip
[description not available]		01.9510
Cancer of Mouth
[description not available]		01.9510
Papilloma, Squamous Cell
[description not available]		01.9510
Cancer of Skin
[description not available]		01.9510
Mouth Neoplasms
Tumors or cancer of the MOUTH.		01.9510
Papilloma
A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)		01.9510
Skin Neoplasms
Tumors or cancer of the SKIN.		01.9510